Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06441045
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-03
Brief Title:
Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Organization Data
Organization:
Fujian Cancer Hospital
Class:
OTHER_GOV
Study ID:
SQS2024-175
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fujian Cancer Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None